Vitamin D, Vitamin A and Lung Cancer Mortality by Mason, Caitlin
September 17, 2012 SCIENCE SPOTLIGHT 
 
1 Volume 2, Issue 9 | Fred Hutchinson Cancer Research Center 
 
Vitamin D, Vitamin A and Lung Cancer Mortality 
September 17, 2012 
     C Mason 
The cause of lung cancer in persons who have never smoked remains uncertain. Yet, vitamin D may 
reduce lung cancer mortality due to its ability to inhibit cell proliferation and promote cell 
differentiation and apoptosis. Normal respiratory epithelial cells have high levels of the vitamin D 
receptor and of the enzyme involved in forming active vitamin D; however, these are dysregulated in 
malignant lung tissues. 
Vitamin A (retinol) is involved in vitamin D-regulated gene transcription but excess dietary levels can 
interrupt this process. Thus, Ting-Yuan David Cheng and Marian Neuhouser of the Public Health 
Sciences Division recently set out to investigate the association between serum 25-hydroxyvitamin 
D, the accepted biomarker of vitamin D status, and death from lung cancer, while taking into account 
smoking status, circulating levels of vitamin A, and vitamin A/β-carotene supplement use. 
In a nationally representative sample of 16,693 men and women from the Third National Health and 
Nutrition Examination Survey, the authors observed an inverse association between serum vitamin 
D and lung cancer mortality among non-smokers, despite no overall association between serum 
vitamin D and lung cancer mortality. Serum vitamin D ≥44 nmol/L vs. <44 nmol/L was associated 
with a 47-69% reduced risk of lung cancer mortality [former/never smokers: Hazard Ratio (HR) 0.53, 
95% Confidence Interval (CI) 0.31-0.91; distant-former (quit ≥20 years)/never smokers: HR 0.31, 
95% CI 0.13-0.77]. Additionally, vitamin A appeared to diminish the inverse association between 
vitamin D and lung cancer mortality, such that the beneficial effect of serum vitamin D ≥44 nmol/L 
was not seen among individuals with excess circulating vitamin A (serum retinyl esters ≥7.0 µg/dL or 
ratio of retinyl esters to retinol ≥0.08) or among vitamin A/β-carotene supplement users, although 
statistical tests to confirm effect modification by vitamin A were not conclusive. 
In this study, the difference between non-smokers with high versus low serum vitamin D translated 
into a lower lung cancer mortality rate by 581 per 10,000. Yet, 29% of this nationally-representative 
sample had excess circulating vitamin A. Thus, if the observed antagonistic actions of excess 
vitamin A and vitamin A/β-carotene supplement use reflect the true underlying etiology, the 
associations between elevated vitamin D levels and reduced lung cancer mortality may have been 
even greater in those with normal levels of vitamin A. 
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Further research to determine the exact level of vitamin A intake that reduces the anti-carcinogenic 
actions of vitamin D are needed and will be important for understanding the true nature of the 
associations between vitamin D and lung cancer development and progression. 
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